7th Intern Conf on AD and Related Disorders in the Middle East
第七届中东 AD 及相关疾病实习生会议
基本信息
- 批准号:9261277
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Abu DhabiAddressAffectAgingAlzheimer&aposs DiseaseAmericasArabsAreaAttentionAwarenessBasic ScienceBehavioralBiotechnologyBrain DiseasesCanadaCaringClinical SciencesCollaborationsCommunicationCommunitiesConsanguinityCountryDementiaDiagnosisDisabled PersonsDiseaseEducationEgyptElderlyEnsureEpidemicEthicsEuropeFeedbackFosteringFundingFutureGenerationsGoalsGovernmentHealthHeartHigh Fat DietHuman ResourcesIndividualInternationalInternshipsInvestigationIranIsraelJordanLeadLearningLebanonLinkLogisticsMedicalMeleagris gallopavoMiddle EastMolecular GeneticsNeurodegenerative DisordersNeurologyNorth AmericaNursesOralPalestinianPaperParticipantPatientsPharmacologic SubstancePharmacologyPoliciesPopulationPopulation SizesPostdoctoral FellowPublic PolicyPublishingQatarQuestionnairesRecording of previous eventsResearchResearch PersonnelSaudi ArabiaScientistSmokingSocial WorkersStudentsSuggestionSyriaTherapeuticTimeTunisiaUnited Arab EmiratesUniversitiesWest BankWomanWorkabstractingage groupagedbaseclinical Diagnosisdementedexperiencefollower of religion Jewishgraduate studenthandicapping conditionimprovedlecturesmedical attentionmeetingsmild cognitive impairmentpostersprofessorprogramssocialsuccesssymposium
项目摘要
Project Summary
Alzheimer’s disease is a major health problem and the leading cause of dementia in the Americas and Europe.
There has been little work done on dementia in the Middle East. This is an important issue because of the
progressive aging of the populations of the world, including the Middle East. For example, the size of the
population of Egyptians 60 years and older is expected to increase by 316% from 2000 to 2030. Also, public
awareness of dementia in the Middle East is low, and in many cases demented patients do not receive medical
attention. The goal of this proposal is to obtain support for the Seventh International Conference on
Alzheimer’s Disease and Related Disorders in the Middle East. The objectives of this conference are to focus
attention on neurodegenerative disorders of the aged, particularly Alzheimer’s disease, in the Middle East, to
raise scientific, medical and social awareness of these disorders, and to enhance communication between
Arab and Jewish medical and scientific personnel, and between Middle Eastern workers and their counterparts
in other countries, particularly the USA. It is anticipated that the meeting will lead to increased studies of
dementia in the Middle East, a region with unique features valuable for research, including a high rate of
consanguinity and smoking, relatively homogenous populations, and high fat diet. Two of the organizers are
from Middle Eastern background and are thoroughly familiar with the cultural traditions of the region, and along
with the past organizer of these conferences, have built continuing collaborative relationships with workers in
the Middle East. A target audience of clinicians, scientists, nurses, social workers, government representatives
and other agencies, pharmaceutical and other biotechnology companies will attend the meeting to be held in
Abu Dhabi, United Arab Emirates, November 4-6, 2016. Attendees will be from the majority of Middle Eastern
countries including Bahrain, Egypt, Iran, Israel, Jordan, Lebanon, Palestinian territories, Qatar, Saudi Arabia,
Syria, Tunisia, Turkey, United Arab Emirates and the West Bank and will include workers from Europe, North
America and other parts of the world. Topics to be covered include clinical and basic science aspects of
dementia, diagnoses, history, management, treatment, and ethics, with consideration of the unique cultural
traditions of Arab and Jewish populations. The organizers have successfully convened six editions of this
conference in the past, and based on past experience expect an even more successful seventh conference.
The seventh conference will build on the success of the past conferences, and will feature a number of new
directions, including holding the conference, for the first time, in the heart of the Middle East.
项目摘要
阿尔茨海默氏病是一个主要的健康问题,也是美洲和欧洲痴呆症的主要原因。
在中东的痴呆症上几乎没有工作。这是一个重要的问题,因为
包括中东在内的世界人口的渐进式衰老。例如,大小
从2000年到2030
中东对痴呆症的认识很低,在许多情况下,痴呆症患者没有接受医疗
注意力。该提案的目的是获得对第七届国际会议的支持
阿尔茨海默氏病和中东相关疾病。这次会议的目标是集中精力
对中东的老年人,特别是阿尔茨海默氏病的神经退行性疾病的注意
提高对这些疾病的科学,医学和社会意识,并增强
阿拉伯和犹太医学和科学人员,中东工人及其同行
在其他国家,特别是美国。预计会议将导致对
中东的痴呆症是一个具有独特研究价值的地区,包括高率
血缘和吸烟,相对同质种群和高脂肪饮食。两个组织者是
从中东背景,非常熟悉该地区的文化传统
随着这些会议的过去组织者,与工人建立了持续的合作关系
中东。临床医生,科学家,护士,社会工作者,政府代表的目标受众
以及其他机构,制药和其他生物技术公司将参加将举行的会议
阿布扎比,阿拉伯联合酋长国,2016年11月4日至6日。与会者将来自中东的大多数
包括巴林,埃及,伊朗,以色列,约旦,黎巴嫩,巴勒斯坦领土,卡塔尔,沙特阿拉伯,
叙利亚,突尼斯,土耳其,阿拉伯联合酋长国和西岸,将包括来自欧洲,北部的工人
美国和世界其他地区。涵盖的主题包括临床和基础科学方面
痴呆,诊断,历史,管理,治疗和道德,并考虑到独特的文化
阿拉伯和犹太人人口的传统。组织者成功召集了六个版本
过去的会议,并基于过去的经验,期望举行更成功的第七届会议。
第七次会议将以过去会议的成功为基础,并将有许多新的
指示,包括首次举行会议,在中东的心脏地带。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHANGIZ GEULA其他文献
CHANGIZ GEULA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHANGIZ GEULA', 18)}}的其他基金
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
认知超级老化:探索对衰老和阿尔茨海默病的恢复力和抵抗力的模型
- 批准号:
10901316 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
研究揭示衰老过程中卓越认知弹性的途径(SUPERAging)
- 批准号:
10276525 - 财政年份:2021
- 资助金额:
$ 5万 - 项目类别:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
研究揭示衰老过程中卓越认知弹性的途径(SUPERAging)
- 批准号:
10687271 - 财政年份:2021
- 资助金额:
$ 5万 - 项目类别:
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
认知超级老化:探索对衰老和阿尔茨海默病的恢复力和抵抗力的模型
- 批准号:
10359727 - 财政年份:2020
- 资助金额:
$ 5万 - 项目类别:
Characterized Adult Primary Human Microglia Cells for Research
用于研究的特征化成人原代人小胶质细胞
- 批准号:
10004183 - 财政年份:2018
- 资助金额:
$ 5万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
- 批准号:
10751224 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
- 批准号:
10826673 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别: